The Hebrew University of Jerusalem and Israel’s Tissue Dynamics again used their “sensors on a chip” to bypass animal testing in developing a new treatment. They proved that the diabetic drug empagliflozin blocks the toxicity of aminoglycoside antibiotics in kidney disease patients.

https://en.huji.ac.il/news/breakthrough-antibiotic-safety-bionic-technology-blends-sensors-and-human-tissue